| View |
|
DR-XY43523
|
Bilastine
|
Bilaxten
|
20mg
|
Tablet
|
Antihistamine
|
A. Menarini Manufacturing Logistics and Services S.R.L.
|
Italy
|
Renewal
|
24 June 2024
|
07 July 2029
|
| View |
|
DR-XY43526
|
Febuxostat
|
Atenurix
|
20mg
|
Film-Coated Tablet
|
Antihyperuricemic
|
Ajanta Pharma Limited
|
India
|
Renewal
|
10 May 2024
|
08 July 2029
|
| View |
|
DR-XY43528
|
CEFUROXIME (AS SODIUM)
|
UROXINE
|
750mg
|
Powder for Injection (IM/IV)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
Hankook Korus Pharm. Co., Ltd.
|
Korea
|
Renewal
|
18 May 2024
|
09 July 2029
|
| View |
|
DR-XY43531
|
Sterile Water for Injection
|
Unbranded
|
50mL
|
Vial Solution
|
Parenteral Solvent / Diluent
|
A.N.B. Laboratories Co. Ltd.
|
Thailand
|
Renewal
|
23 May 2024
|
09 July 2029
|
| View |
|
DR-XY43535
|
Warfarin Sodium ( as Clathrate)
|
Coufarin
|
5 mg
|
Tablet
|
Anticoagulant
|
Unicure Remedies Pvt. Ltd.
|
India
|
Renewal
|
15 June 2024
|
14 July 2029
|
| View |
|
DR-XY43539
|
Adenosine
|
Adesan
|
3mg/mL (6mg/2mL)
|
Solution For Iv Injection
|
Antiarrhythmic Agent
|
Bharat Parenterals Ltd.
|
India
|
Automatic Renewal
|
09 October 2021
|
12 October 2026
|
| View |
|
DR-XY43548
|
Imidafenacin
|
Uritos
|
100mcg
|
Film-Coated Tablet
|
Muscarinic Receptor Antagonist
|
Kyorin Pharmaceutical Group Facilities Co., Ltd. (Noshiro Plant)
|
Japan
|
Renewal
|
26 July 2023
|
21 July 2029
|
| View |
|
DR-XY43554
|
Aspirin
|
Enduprin
|
100mg
|
Enteric-Coated Tablet
|
Antithrombotic
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
12 June 2024
|
23 July 2029
|
| View |
|
DR-XY43557
|
Zoledronic Acid
|
Zoledra
|
4mg/5mL
|
Solution For I.V. Infusion
|
Biphosphonate
|
Gland Pharma Limited
|
India
|
Renewal
|
25 June 2024
|
25 July 2029
|
| View |
|
DR-XY43560
|
Mupirocin
|
Bactreat
|
20mg/g (2%)
|
Ointment
|
Antibacterial
|
Yash Medicare Pvt. Ltd.
|
India
|
Renewal
|
02 May 2024
|
23 July 2029
|
| View |
|
DR-XY43564
|
Triamcinolone Acetonide
|
None
|
1 mg/mL (0.1% w/v)
|
Lotion
|
Topical Costecosteroid
|
DS Cosmeceutical Manufacturing Laboratory
|
Philippines
|
Renewal
|
25 May 2022
|
30 July 2026
|
| View |
|
DR-XY43570
|
Olanzapine
|
Nykob
|
5 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Genepharm S.A.
|
Greece
|
Renewal
|
19 May 2024
|
30 July 2029
|
| View |
|
DR-XY43571
|
Olanzapine
|
Nykob
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Genepharm S.A.
|
Greece
|
Renewal
|
11 June 2024
|
30 July 2029
|
| View |
|
DR-XY43579
|
Levocetirizine dihydrochloride
|
Levoride
|
5 mg
|
Film-Coated Tablet
|
Antihistamine
|
Oman Pharmaceutical Products Co., L.L.C.
|
Oman
|
Renewal
|
23 May 2024
|
31 July 2029
|
| View |
|
DR-XY43584
|
Multivitamins + Minerals (see formulation on reverse side)
|
Mosvit Elite
|
|
Capsule, soft gelatin
|
Vitamins and Minerals
|
Olive Healthcare
|
India
|
Renewal
|
02 August 2024
|
04 August 2029
|
| View |
|
DR-XY43587
|
Irbesartan
|
Unbranded
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
01 April 2024
|
05 August 2029
|
| View |
|
DR-XY43595
|
Co-Amoxiclav
|
Comolav
|
500mg/125mg
|
Film-Coated Tablet
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
07 July 2024
|
16 September 2029
|
| View |
|
DR-XY43597
|
Terlipressin acetate
|
Glypressin
|
100mcg/mL
|
Solution For Injection (IV)
|
Vasopressin and analogues
|
Zentiva K.S.
|
Czech Republic
|
Renewal
|
18 May 2024
|
06 August 2029
|
| View |
|
DR-XY43598
|
Losartan Potassium + Hydrochlorothiazide
|
Vamzar Plus
|
50 mg/12.5 mg
|
Fim-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
26 April 2024
|
06 August 2029
|
| View |
|
DR-XY43601
|
Clindamycin Phosphate
|
Clinmyn
|
150mg/mL
|
Solution For Injection
|
Antibacterial (Lincosamide)
|
Samjin Pharmaceutical, Co. Ltd.
|
South Korea
|
Automatic Renewal
|
12 December 2022
|
08 August 2027
|